Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22137| Title: | Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome. | Austin Authors: | Wong, Jonathan;Cher, Lawrence M ;Griffiths, James;Cohen, Aileen;Huang, Jane;Wang, Lai;Gregory, Gareth;Opat, Stephen | Affiliation: | Department of Hematology, Monash Health, Clayton, Victoria, Australia Monash University, Clayton, Victoria, Australia Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia BeiGene Company Ltd, San Mateo, CA, USA |
Issue Date: | Dec-2018 | Date: | 2018 | Publication information: | HemaSphere 2018; 2(6): e155 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/22137 | DOI: | 10.1097/HS9.0000000000000155 | Journal: | HemaSphere | PubMed URL: | 31723793 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.